ART4 and breast carcinoma: PODXL is a negatively charged sialic acid glycoprotein, belonging to the type I transmembrane glycoprotein, which has been reported to be associated with poor prognosis in oral squamous cell carcinoma, colon cancer, glioblastoma, and breast cancer and has an impact on cell adhesion and migration.